StockGlow

Compugen Ltd. (CGEN.TA)

Compugen Ltd., a clinical-stage therapeutic discovery and development company, engages in the research, development, and commercialization of therapeutics and product candidates in Israel, the United States, and Europe.

691.10-0.01%Healthcare
Compare CGEN.TA with
StockGlow Score
74
Leaning Bullish
BearishBullish
1 year ago+37.5%

The outlook

Compugen Ltd. currently reads as leaning bullish based on above its 50- & 200-day averages, 52% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.

What’s behind the score

Price trendAbove its 50- & 200-day averages
52-week range52% of the way from its 52-week low to high
Market cap
$653.7M
52-wk high
924.00
52-wk low
435.00
50-day avg
680.62
200-day avg
636.47
Trailing P/E
6.0

Similar stocks

KMDA.TAKamada Ltd.$2,227.00+3.05%EVGN.TAEvogene Ltd.$162.00+5.13%TSEM.TATower Semiconductor Ltd.$67,700.00+4.48%AUDC.TAAudioCodes Ltd.$2,849.00+2.52%NICE.TANICE LTD$29,750.00+0.27%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy